Angiogenesis in cancer and other diseases
The DOI matches its Crossref record; 71 of the 72 references it cites were found in a registry or an index.
Abstract
Pathological angiogenesis is a hallmark of cancer and various ischaemic and inflammatory diseases. Concentrated efforts in this area of research are leading to the discovery of a growing number of pro- and anti-angiogenic molecules, some of which are already in clinical trials. The complex interactions among these molecules and how they affect vascular structure and function in different environments are now beginning to be elucidated. This integrated understanding is leading to the development of a number of exciting and bold approaches to treat cancer and other diseases. But owing to several unanswered questions, caution is needed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The presence of vascularization is one of the landmarks of tumor environments [57,180].”
From The Tumor-on-Chip: Recent Advances in the Development of Microfluidic Systems to Recapitulate the Physiology of Solid Tumors (2019) · cites this paper as [180]
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Endostatin: an endogenous inhibitor of angiogenesis and tumor growth
O'Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olsen, B. R., & Folkman, J. (1997) · Cell · doi:10.1016/s0092-8674(00)81848-6 · Cited by 4,486 · cited 1×
“This hypothesis formed the basis of the discovery of angiostatin, endostatin, vasculostatin and other endogenous inhibitors of angiogenesi”
BackgroundMechanisms of angiogenesis and arteriogenesis
Carmeliet, P. (2000) · Nature Medicine · doi:10.1038/74651 · Cited by 4,162 · cited 1×
“We now know there are various molecular players involved in these different mechanisms of vascular growt”
BackgroundSelf-citationAbnormal blood vessel development and lethality in embryos lacking a single VEGF allele
Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein, M., Fahrig, M., Vandenhoeck, A., Harpal, K., Eberhardt, C., et al. (1996) · Nature · doi:10.1038/380435a0 · Cited by 4,117
Self-citationO'Reilly, M. (1994) · Cell · doi:10.1016/0092-8674(94)90200-3 · Cited by 3,345 · cited 1×
“This hypothesis formed the basis of the discovery of angiostatin, endostatin, vasculostatin and other endogenous inhibitors of angiogenesi”
BackgroundRole of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
Carmeliet, P., Dor, Y., Herbert, J.-M., Fukumura, D., Brusselmans, K., Dewerchin, M., Neeman, M., Bono, F., Abramovitch, R., Maxwell, P., et al. (1998) · Nature · doi:10.1038/28867 · Cited by 2,502 · cited 1×
“However, caution is warranted as these hypoxia-inducible factors could also control cell deat”
BackgroundSelf-citationRegulation of transport pathways in tumor vessels: Role of tumor type and microenvironment
Hobbs, S. K., Monsky, W. L., Yuan, F., Roberts, W. G., Griffith, L., Torchilin, V. P., & Jain, R. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4607 · Cited by 2,438
Self-citationCancer Treatment by Targeted Drug Delivery to Tumor Vasculature in a Mouse Model
Arap, W., Pasqualini, R., & Ruoslahti, E. (1998) · Science · doi:10.1126/science.279.5349.377 · Cited by 2,054 · cited 1×
“In vivo selection of phage display libraries has recently yielded peptides (for example, amino-acid sequences RGD and NGR) that preferentially recognize vessels in subcutaneous tumours in mic”
BackgroundOpenings Between Defective Endothelial Cells Explain Tumor Vessel Leakiness
Hashizume, H., Baluk, P., Morikawa, S., McLean, J. W., Thurston, G., Roberge, S., Jain, R. K., & McDonald, D. M. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65006-7 · Cited by 1,689
Self-citationHelmlinger, G., Yuan, F., Dellian, M., & Jain, R. K. (1997) · Nature Medicine · doi:10.1038/nm0297-177 · Cited by 1,628
Self-citation
Research works printed but not linked: 8
- Greenblatt, M. & Shubik, P. Tumor angiogenesis: transfilter diffusion studies in the hamster by the transparant chamber technique. J. Natl Cancer Inst. 41, 111–124 (1968).
- Ehrmann, R. L. & Knoth, M. Choriocarcinoma: transfilter stimulation of vasoproliferation in the hamster cheek pouch studied by light and electron microscopy. J. Natl Cancer Inst. 41, 1329 –1341 (1968).
- Folkman, J. in Cancer Medicine (eds Holland, J. F. et al.) 132– 152 (Decker, Ontario, Canada, 2000).
- Chang, Y. S. et al. Abundance of neoplastic cells in vessel walls of human tumor xenografts. Proc. Am. Assoc. Cancer Res. (in the press).
- Seljelid, R., Jozefowski, S. & Sveinbjornsson, B. Tumor stroma. Anticancer Res. 19, 4809–4822 (1999).
- Buschmann, I. & Schaper, W. The pathophysiology of the collateral circulation (arteriogenesis). J. Pathol. 190, 338–342 (2000). · doi:10.1002/(sici)1096-9896(200002)190:3<338::aid-path594>3.0.co;2-7
- Carmeliet, P. & Collen, D. Transgenic mouse models in angiogenesis and cardiovascular disease. J. Pathol. 190, 387–405 (2000). · doi:10.1002/(sici)1096-9896(200002)190:3<387::aid-path595>3.0.co;2-r
- Tsuzuki, Y. et al. VEGF modulation by targeting HIF-1alpha/HRE/VEGF cascade differentially regulates vascular response and growth rate in tumors. Cancer Res. (in the press).
Cited by
Items 201–300 of 1,084
Ozawa, C. R., Banfi, A., Glazer, N. L., Thurston, G., Springer, M. L., Kraft, P. E., McDonald, D. M., & Blau, H. M. (2004) · Journal of Clinical Investigation · doi:10.1172/jci18420 · Cited by 520
Cell migration into scaffolds under co-culture conditions in a microfluidic platform
Chung, S., Sudo, R., Mack, P. J., Wan, C.-R., Vickerman, V., & Kamm, R. D. (2009) · Lab Chip · doi:10.1039/b807585a · Cited by 519
Tian, S., Quan, H., Xie, C., Guo, H., Lü, F., Xu, Y., Li, J., & Lou, L. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.01939.x · Cited by 513
Molecular Pharmacology of VEGF-A Isoforms: Binding and Signalling at VEGFR2
Peach, C. J., Mignone, V. W., Arruda, M. A., Alcobia, D. C., Hill, S. J., Kilpatrick, L. E., & Woolard, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041264 · Cited by 512
TIMP-2 Mediated Inhibition of Angiogenesis
Seo, D.-W., Li, H., Guedez, L., Wingfield, P. T., Diaz, T., Salloum, R., Wei, B.-Y., & Stetler-Stevenson, W. G. (2003) · Cell · doi:10.1016/s0092-8674(03)00551-8 · Cited by 508
Angiogenesis and chronic inflammation: cause or consequence?
Costa, C., Incio, J., & Soares, R. (2007) · Angiogenesis · doi:10.1007/s10456-007-9074-0 · Cited by 504
“Coordination of angiogenesis is accomplished by a variety of activators and inhibitors that sequentially synchronize the complex series of events [21].”
BackgroundInfluentialInterplay between ROS and autophagy in cancer cells, from tumor initiation to cancer therapy
Poillet-Perez, L., Despouy, G., Delage-Mourroux, R., & Boyer-Guittaut, M. (2015) · Redox Biology · doi:10.1016/j.redox.2014.12.003 · Cited by 503
“Angiogenesis is a key step during tumor growth and metastasis [100] but the relationship between angiogenesis and autophagy is poorly understood.”
BackgroundPericytes and vascular stability
VONTELL, D., ARMULIK, A., & BETSHOLTZ, C. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.10.019 · Cited by 502
Bos, R., van der Groep, P., Greijer, A. E., Shvarts, A., Meijer, S., Pinedo, H. M., Semenza, G. L., van Diest, P. J., & van der Wall, E. (2003) · Cancer · doi:10.1002/cncr.11246 · Cited by 500
Fluid forces control endothelial sprouting
Song, J. W., & Munn, L. L. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105316108 · Cited by 498
“We speculate that, whereas VEGF guides sprouts toward hypoxic regions (1, 5, 9), interstitial flow directs them to other vessels, against the direction of interstitial flow, and consequently, toward vessels that have higher microvascular pressure than their own.”
BackgroundInfluentialPeptide and protein nanoparticle conjugates: versatile platforms for biomedical applications
Spicer, C. D., Jumeaux, C., Gupta, B., & Stevens, M. M. (2018) · Chemical Society Reviews · doi:10.1039/c7cs00877e · Cited by 497
Kievit, F. M., & Zhang, M. (2011) · Advanced Materials · doi:10.1002/adma.201102313 · Cited by 496
Targeted therapy using nanotechnology: focus on cancer
Sechi, M., Sanna, V., & Pala, N. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s36654 · Cited by 493
“Anatomically, tumor microvasculature is leaky and characterized by abnormal branching and enlarged interendothelial gaps, with associated breakdown of tight junctions between endothelial cells and a disrupted basement membrane.(63) These large gaps between endothelial cells facilitate the extravasation of particulate…”
BackgroundMiR-21 Induced Angiogenesis through AKT and ERK Activation and HIF-1α Expression
Liu, L.-Z., Li, C., Chen, Q., Jing, Y., Carpenter, R., Jiang, Y., Kung, H.-F., Lai, L., & Jiang, B.-H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019139 · Cited by 493
“Tumor angiogenesis is the process that new vessels sprout from preexisting blood vessels [13].”
BackgroundDuluc, D., Delneste, Y., Tan, F., Moles, M.-P., Grimaud, L., Lenoir, J., Preisser, L., Anegon, I., Catala, L., Ifrah, N., et al. (2007) · Blood · doi:10.1182/blood-2007-02-072587 · Cited by 491
Sudhakar, A., Sugimoto, H., Yang, C., Lively, J., Zeisberg, M., & Kalluri, R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0730882100 · Cited by 488
Ion Channels in Cancer: Are Cancer Hallmarks Oncochannelopathies?
Prevarskaya, N., Skryma, R., & Shuba, Y. (2018) · Physiological Reviews · doi:10.1152/physrev.00044.2016 · Cited by 484
Dadras, S. S., Paul, T., Bertoncini, J., Brown, L. F., Muzikansky, A., Jackson, D. G., Ellwanger, U., Garbe, C., Mihm, M. C., & Detmar, M. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64328-3 · Cited by 484
“In contrast, a traditional view asserts that lymphatic endothelium plays a passive role during tumor metastasis and that lymphatic invasion only occurs via infiltrating tumor cells invading pre-existing lymphatic vessels.(41) However, several studies in animal tumor models provide direct experimental evidence that inc…”
BackgroundCheng, G., Tse, J., Jain, R. K., & Munn, L. L. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004632 · Cited by 478
“rameters, such as hypoxia [1,2] and angiogenesis [3–5], mechanical”
BackgroundSelf-citationPolymeric micelles for nano-scale drug delivery
Miyata, K., Christie, R. J., & Kataoka, K. (2011) · Reactive and Functional Polymers · doi:10.1016/j.reactfunctpolym.2010.10.009 · Cited by 478
Tohyama, O., Matsui, J., Kodama, K., Hata-Sugi, N., Kimura, T., Okamoto, K., Minoshima, Y., Iwata, M., & Funahashi, Y. (2014) · Journal of Thyroid Research · doi:10.1155/2014/638747 · Cited by 475
The Intersection between Tumor Angiogenesis and Immune Suppression
Rahma, O. E., & Hodi, F. S. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-1543 · Cited by 472
“The VEGF family, consisting of six growth factors (VEGFA-F), plays the most critical role in angiogenesis by binding to their receptors VEGFR1-3 and neuropilin (4).”
BackgroundA critical analysis of current in vitro and in vivo angiogenesis assays
Staton, C. A., Reed, M. W. R., & Brown, N. J. (2009) · International Journal of Experimental Pathology · doi:10.1111/j.1365-2613.2008.00633.x · Cited by 469
“Angiogenesis, the development of new blood vessels from the existing vasculature, is essential in normal developmental processes and is a hallmark of over 50 different disease states including cancer, rheumatoid arthritis and psoriasis (Carmeliet & Jain 2000).”
BackgroundAntiangiogenic Properties of Gold Nanoparticles
Mukherjee, P., Bhattacharya, R., Wang, P., Wang, L., Basu, S., Nagy, J. A., Atala, A., Mukhopadhyay, D., & Soker, S. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2482 · Cited by 468
“Angiogenesis, the formation of new blood vessels is essential for the growth and progression of tumors (1, 2).”
BackgroundSignificance of blood vessel leakiness in cancer.
McDonald, D. M., & Bałuk, P. (2002) · PubMed · Cited by 561
In Vivo Acoustic Super-Resolution and Super-Resolved Velocity Mapping Using Microbubbles
Christensen-Jeffries, K. M., Browning, R. J., Tang, M., Dunsby, C. W., & Eckersley, R. J. (2014) · IEEE Transactions on Medical Imaging · doi:10.1109/tmi.2014.2359650 · Cited by 465
Boucharaba, A., Serre, C.-M., Grès, S., Saulnier-Blache, J. S., Bordet, J.-C., Guglielmi, J., Clézardin, P., & Peyruchaud, O. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422123 · Cited by 462
“Third, because of the leaky vasculature of angiogenic tumors (35), platelets are in contact with tumor cells and are therefore able to secrete multiple factors upon activation (36).”
BackgroundNew approaches for imaging tumour responses to treatment
Brindle, K. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2289 · Cited by 460
“This process of angiogenesis is essential for tumour invasion and subsequent metastasis and increased angiogenesis is normally associated with poor prognosi”
BackgroundHypoxia inducible factors in cancer stem cells
Heddleston, J. M., Li, Z., Lathia, J. D., Bao, S., Hjelmeland, A. B., & Rich, J. N. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605551 · Cited by 452
“The chaotic vessel formation is another factor in the constant oxygen flux observed in solid tumours (Carmeliet and Jain, 2000).”
BackgroundVEGF165b, an Inhibitory Vascular Endothelial Growth Factor Splice Variant
Woolard, J., Wang, W.-Y., Bevan, H. S., Qiu, Y., Morbidelli, L., Pritchard-Jones, R. O., Cui, T.-G., Sugiono, M., Waine, E., Perrin, R., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0934 · Cited by 451
FUKUMURA, D., DUDA, D. G., MUNN, L. L., & JAIN, R. K. (2010) · Microcirculation · doi:10.1111/j.1549-8719.2010.00029.x · Cited by 451
“IVM has provided unique insights into angiogenesis and tumor biology [12,34,36,71,86].”
BackgroundSelf-citationMiyata, K., Nishiyama, N., & Kataoka, K. (2012) · Chem. Soc. Rev. · doi:10.1039/c1cs15258k · Cited by 451
Vascular Endothelial Growth Factor as an Anti-Angiogenic Target for Cancer Therapy
Niu, G., & Chen, X. (2010) · Current Drug Targets · doi:10.2174/138945010791591395 · Cited by 451
PAGES, G., & POUYSSEGUR, J. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.09.032 · Cited by 443
“After this first characterization, the importance of VEGF in normal and pathological angiogenesis processes [4], as well as protection against motor neurons degeneration [5,6], has been demonstrated.”
BackgroundVascular Growth Factors and Lymphangiogenesis
Jussila, L., & Alitalo, K. (2002) · Physiological Reviews · doi:10.1152/physrev.00005.2002 · Cited by 443
Ingram, D. A., Caplice, N. M., & Yoder, M. C. (2005) · Blood · doi:10.1182/blood-2005-04-1509 · Cited by 442
Nishimura, S., Manabe, I., Nagasaki, M., Hosoya, Y., Yamashita, H., Fujita, H., Ohsugi, M., Tobe, K., Kadowaki, T., Nagai, R., et al. (2007) · Diabetes · doi:10.2337/db06-1749 · Cited by 440
“13), suggesting the involvement of ROS and HIF-1 signaling in the production of VEGF (32).”
Fukumura, D., Xu, L., Chen, Y., Gohongi, T., Seed, B., & Jain, R. K. (2001) · PubMed · Cited by 523
Self-citationPolymeric nanoparticles for targeted treatment in oncology: current insights
Joshi, M. D., Patravale, V., & Prabhu, R. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s56932 · Cited by 438
“blood vessel fenestration and be entrapped in the tumor due to higher retention ability than the normal tissues.(5,7,8)”
Pathological angiogenesis is induced by sustained Akt signaling and inhibited by rapamycin
Phung, T. L., Ziv, K., Dabydeen, D., Eyiah-Mensah, G., Riveros, M., Perruzzi, C., Sun, J., Monahan-Earley, R. A., Shiojima, I., Nagy, J. A., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.07.003 · Cited by 438
“While heterogeneous, many tumor blood vessels are enlarged and tortuous, and compared to normal vessels of similar sizes, they are poorly invested by pericytes and have defective basement membranes (Baluk et al., 2003; Carmeliet and Jain, 2000; Morikawa et al., 2002).”
BackgroundModelling solid tumour growth using the theory of mixtures
Byrne, H. (2003) · Mathematical Medicine and Biology · doi:10.1093/imammb/20.4.341 · Cited by 437
Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors
Casanova, M., Blázquez, C., Martínez‐Palacio, J., Villanueva, C., Fernández‐Aceñero, M. J., Huffman, J. W., Jorcano, J. L., & Guzmán, M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16116 · Cited by 437
“For that purpose they produce proangiogenic factors that promote the formation of new blood vessels (28, 29).”
BackgroundAdya, R., Tan, B. K., Punn, A., Chen, J., & Randeva, H. S. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvm111 · Cited by 437
“factors seems beneficial in certain ophthalmic conditions, atherosclerotic plaques, and so on, the reverse is required in inducing angiogenesis for improving macro-vascular insufficiency, for example in peripheral limb ischaemia.(22) Therefore, the study of VEGF–MMP system assumes crucial importance.”
BackgroundNepali, K., Sharma, S., Sharma, M., Bedi, P. M. S., & Dhar, K. L. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.03.018 · Cited by 435
Dual targeting strategies with bispecific antibodies
Kontermann, R. (2012) · mAbs · doi:10.4161/mabs.4.2.19000 · Cited by 435
Insights into the mechanisms of lymph node metastasis
Nathanson, S. D. (2003) · Cancer · doi:10.1002/cncr.11464 · Cited by 433
“Recent work has demonstrated the potential importance of the induction of lymphangiogenesis by cytokines that are secreted by tumor cells or by host cells and stroma.(70) It remains unknown whether directional motility toward the lymphatics is purely mechanical (i.”
BackgroundHypoxia-induced vascular endothelial growth factor expression causes vascular leakage in the brain
Schoch, H. J. (2002) · Brain · doi:10.1093/brain/awf257 · Cited by 433
“We wish to thank M. Euler for technical assistance and Lara Ogunshola and Roland H. Wenger for critically reading the manuscript.”
The seed and soil hypothesis: vascularisation and brain metastases
Fidler, I. J., Yano, S., Zhang, R.-D., Fujimaki, T., & Bucana, C. D. (2002) · The Lancet Oncology · doi:10.1016/s1470-2045(01)00622-2 · Cited by 432
Quantum dots spectrally distinguish multiple species within the tumor milieu in vivo
Stroh, M., Zimmer, J. P., Duda, D. G., Levchenko, T. S., Cohen, K. S., Brown, E. B., Scadden, D. T., Torchilin, V. P., Bawendi, M. G., Fukumura, D., et al. (2005) · Nature Medicine · doi:10.1038/nm1247 · Cited by 432
“Tracking bone marrow–derived cells Tissue neovascularization involves both the participation of local endothelial cells and the recruitment of circulating progenitor cell”
Self-citationMicrofluidics‐Enabled Multimaterial Maskless Stereolithographic Bioprinting
Miri, A. K., Nieto, D., Iglesias, L., Goodarzi Hosseinabadi, H., Maharjan, S., Ruiz‐Esparza, G. U., Khoshakhlagh, P., Manbachi, A., Dokmeci, M. R., Chen, S., et al. (2018) · Advanced Materials · doi:10.1002/adma.201800242 · Cited by 431
Lactate: mirror and motor of tumor malignancy
Walenta, S., & Mueller-Klieser, W. F. (2004) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2004.04.004 · Cited by 428
The organ microenvironment and cancer metastasis
Fidler, I. J. (2002) · Differentiation · doi:10.1046/j.1432-0436.2002.700904.x · Cited by 426
“, angiogenesis (Carmeliet and Jain, 2000; Folkman, 1995).”
Tumor Microenvironment and Differential Responses to Therapy
Hirata, E., & Sahai, E. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026781 · Cited by 422
Feng, L., Xie, R., Wang, C., Gai, S., He, F., Yang, D., Yang, P., & Lin, J. (2018) · ACS Nano · doi:10.1021/acsnano.8b05042 · Cited by 422
Kryczek, I., Lange, A., Mottram, P., Alvarez, X., Cheng, P., Hogan, M., Moons, L., Wei, S., Zou, L., Machelon, V., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.465.65.2 · Cited by 421
“(4) CXCL12 and VEGF synergistically promote vascular endothelial cell function, including migration, expansion, and survival.”
BackgroundInfluentialSelf-citationEngineered nanomedicines with enhanced tumor penetration
Ding, J., Chen, J., Gao, L., Jiang, Z., Zhang, Y., Li, M., Xiao, Q., Lee, S. S., & Chen, X. (2019) · Nano Today · doi:10.1016/j.nantod.2019.100800 · Cited by 420
Pencheva, N., Tran, H., Buss, C., Huh, D., Drobnjak, M., Busam, K., & Tavazoie, S. F. (2012) · Cell · doi:10.1016/j.cell.2012.10.028 · Cited by 415
“…key attribute of metastatic cells from multiple epithelial cancer types and suggest a significant role for cancer-endothelial interactions in metastatic initiation and progression that complements their established conventional roles in primary tumor growth and perfusion (Carmeliet and Jain, 2000).”
In vivo dark-field reflection-mode photoacoustic microscopy
Maslov, K., Stoica, G., & Wang, L. V. (2005) · Optics Letters · doi:10.1364/ol.30.000625 · Cited by 413
Heparin Binding Nanostructures to Promote Growth of Blood Vessels
Rajangam, K., Behanna, H. A., Hui, M. J., Han, X., Hulvat, J. F., Lomasney, J. W., & Stupp, S. I. (2006) · Nano Letters · doi:10.1021/nl0613555 · Cited by 412
Lampugnani, M. G., Zanetti, A., Corada, M., Takahashi, T., Balconi, G., Breviario, F., Orsenigo, F., Cattelino, A., Kemler, R., Daniel, T. O., et al. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200209019 · Cited by 410
“VEGF plays an important role in the formation of new vessels during embryogenesis and in proliferative diseases in the adult (Ferrara and Alitalo, 1999; Carmeliet and Jain, 2000; Dor et al., 2002).”
BackgroundHeparan Sulfate: A Complex Polymer Charged with Biological Activity
Whitelock, J. M., & Iozzo, R. V. (2005) · Chemical Reviews · doi:10.1021/cr010213m · Cited by 410
Novel functions of TIMPs in cell signaling
Chirco, R., Liu, X.-W., Jung, K.-K., & Kim, H.-R. C. (2006) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-7893-x · Cited by 401
“endothelial cell invasion within an interstitial matrix [97, 98].”
BackgroundSignaling by members of the TGF-β family in vascular morphogenesis and disease
Pardali, E., Goumans, M.-J., & ten Dijke, P. (2010) · Trends in Cell Biology · doi:10.1016/j.tcb.2010.06.006 · Cited by 401
Wang, B., Xiao, Y., Ding, B.-B., Zhang, N., Yuan, X.-B., Gui, L., Qian, K.-X., Duan, S., Chen, Z., Rao, Y., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00164-8 · Cited by 398
Yankeelov, T., & Gore, J. (2007) · Current Medical Imaging Reviews · doi:10.2174/157340507780619179 · Cited by 398
“It is believed that virtually all solid tumors are dependent upon angiogenesis for survival [5], and many anti-angiogenic drugs are currently in clinical trials [6].”
BackgroundHuinen, Z. R., Huijbers, E. J. M., van Beijnum, J. R., Nowak-Sliwinska, P., & Griffioen, A. W. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00496-y · Cited by 395
Function of cGMP-Dependent Protein Kinases as Revealed by Gene Deletion
Hofmann, F., Feil, R., Kleppisch, T., & Schlossmann, J. (2006) · Physiological Reviews · doi:10.1152/physrev.00015.2005 · Cited by 395
“Thus it appears that cGKI mediates, at least in part, the stimulatory effect of NO in pathological angiogenesis, a hallmark of cancer and various ischemic and inflammatory diseases (33).”
BackgroundDifferential gene expression during capillary morphogenesis in 3D collagen matrices
Bell, S. E., Mavila, A., Salazar, R., Bayless, K. J., Kanagala, S., Maxwell, S. A., & Davis, G. E. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.15.2755 · Cited by 395
Nolan, D. J., Ciarrocchi, A., Mellick, A. S., Jaggi, J. S., Bambino, K., Gupta, S., Heikamp, E., McDevitt, M. R., Scheinberg, D. A., Benezra, R., et al. (2007) · Genes & Development · doi:10.1101/gad.436307 · Cited by 394
“The angiogenic switch involves the formation of new blood vessels (neovasculature), and is a hallmark of cancer emergence and progression (Folkman 1971; Hanahan and Folkman 1996; Carmeliet and Jain 2000).”
BackgroundPerfusion CT: a worthwhile enhancement?
Miles, K. A., & Griffiths, M. R. (2003) · The British Journal of Radiology · doi:10.1259/bjr/13564625 · Cited by 392
Martin, D., Galisteo, R., & Gutkind, J. S. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.c800207200 · Cited by 388
Skobe, M., Hamberg, L. M., Hawighorst, T., Schirner, M., Wolf, G. L., Alitalo, K., & Detmar, M. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61765-8 · Cited by 388
“Whereas the significance of angiogenesis in tumors has been well documented, the ability of tumor cells to stimulate lymphangiogenesis and the existence of intratumoral lymphatic vessels have remained controversial.(8,9,51) Expression of the lymphangiogenic factor VEGF-C has been detected in many tumor types including…”
BackgroundMelissa officinalis L. – A review of its traditional uses, phytochemistry and pharmacology
Shakeri, A., Sahebkar, A., & Javadi, B. (2016) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2016.05.010 · Cited by 386
Karamysheva, A. F. (2008) · Biochemistry (Moscow) · doi:10.1134/s0006297908070031 · Cited by 386
Angiogenesis Ischemic and Neoplastic Disorders
Semenza, G. L. (2003) · Annual Review of Medicine · doi:10.1146/annurev.med.54.101601.152418 · Cited by 386
Application of semiconductor quantum dots in bioimaging and biosensing
Martynenko, I. V., Litvin, A. P., Purcell-Milton, F., Baranov, A. V., Fedorov, A. V., & Gun'ko, Y. K. (2017) · Journal of Materials Chemistry B · doi:10.1039/c7tb01425b · Cited by 382
Humar, R., Kiefer, F. N., Berns, H., Resink, T. J., & Battegay, E. J. (2002) · The FASEB Journal · doi:10.1096/fj.01-0658com · Cited by 381
“larization (3, 8, 9), proliferation and remodeling of the”
BackgroundMiR-210 – micromanager of the hypoxia pathway
Huang, X., Le, Q.-T., & Giaccia, A. J. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.03.004 · Cited by 376
Oliver, G., & Detmar, M. (2002) · Genes & Development · doi:10.1101/gad.975002 · Cited by 375
“…has indeed been shown to be specifically expressed by lymphatics in normal murine and human tissues (with the exception of liver sinusoidal endothelial cells that are strongly involved in hyaluronan uptake; Carreira et al. 2001) and in tumors of both murine and human origin (Wigle et al. 2002).”
BackgroundVascularized organoid engineered by modular assembly enables blood perfusion
McGuigan, A. P., & Sefton, M. V. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602740103 · Cited by 372
Mechanisms regulating T-cell infiltration and activity in solid tumors
Lanitis, E., Dangaj, D., Irving, M., & Coukos, G. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx238 · Cited by 369
The endothelial-cell-derived secreted factor Egfl7 regulates vascular tube formation
Parker, L. H., Schmidt, M., Jin, S.-W., Gray, A. M., Beis, D., Pham, T., Frantz, G., Palmieri, S., Hillan, K., Stainier, D. Y. R., et al. (2004) · Nature · doi:10.1038/nature02416 · Cited by 369
“A number of secreted factors produced by surrounding cells regulate endothelial cell (EC) differentiation, proliferation, migration and coalescence into cord-like structure”
BackgroundA novel siRNA-lipoplex technology for RNA interference in the mouse vascular endothelium
Santel, A., Aleku, M., Keil, O., Endruschat, J., Esche, V, Fisch, G., Dames, S., Löffler, K., Fechtner, M., Arnold, W., et al. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302777 · Cited by 368
Nanoparticle-Mediated Combination Therapy: Two-in-One Approach for Cancer
Gurunathan, S., Kang, M.-H., Qasim, M., & Kim, J.-H. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103264 · Cited by 367
“The abnormal vascular structure leads to increased levels of vascular endothelial growth factor (VEGF) and decreases the effectiveness of cytotoxic chemotherapy [8,12].”
BackgroundInfluentialNovel concepts in atherogenesis: angiogenesis and hypoxia in atherosclerosis
Sluimer, J. C., & Daemen, M. J. (2009) · The Journal of Pathology · doi:10.1002/path.2518 · Cited by 367
“Endogenous angiostatic factors include cleavage fragments of collagen XVIII and plasminogen (endostatin and angiostatin, respectively), platelet factor 4 (PF4), and thrombospondin 1 (TSP1) [65], which were also shown to be enhanced with progressive atherogenesis.”
BackgroundHaplotype analysis of the polymorphic human vascular endothelial growth factor gene promoter.
Stevens, A., Soden, J., Brenchley, P. E., Ralph, S., & Ray, D. W. (2003) · PubMed · Cited by 367
Sex differences in cancer mechanisms
Rubin, J. B., Lagas, J. S., Broestl, L., Sponagel, J., Rockwell, N., Rhee, G., Rosen, S. F., Chen, S., Klein, R. S., Imoukhuede, P., et al. (2020) · Biology of Sex Differences · doi:10.1186/s13293-020-00291-x · Cited by 366
Lymphangiogenesis and tumor metastasis: myth or reality?
Pepper, M. S. (2001) · PubMed · Cited by 418
Paracrine Regulation of Angiogenesis and Adipocyte Differentiation During In Vivo Adipogenesis
Fukumura, D., Ushiyama, A., Duda, D. G., Xu, L., Tam, J., Krishna, V., Chatterjee, K., Garkavtsev, I., & Jain, R. K. (2003) · Circulation Research · doi:10.1161/01.res.0000099243.20096.fa · Cited by 365
Self-citationSluimer, J. C., Kolodgie, F. D., Bijnens, A. P. J. J., Maxfield, K., Pacheco, E., Kutys, B., Duimel, H., Frederik, P. M., van Hinsbergh, V. W. M., Virmani, R., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.12.056 · Cited by 365
“Microvessels with all junctions open 33% (8)”
InfluentialFeng, S.-S., & Chien, S. (2003) · Chemical Engineering Science · doi:10.1016/s0009-2509(03)00234-3 · Cited by 364
Mason, B. N., Starchenko, A., Williams, R. M., Bonassar, L. J., & Reinhart-King, C. A. (2013) · Acta Biomaterialia · doi:10.1016/j.actbio.2012.08.007 · Cited by 363
The role of VEGF in cancer-induced angiogenesis and research progress of drugs targeting VEGF
Ghalehbandi, S., Yuzugulen, J., Pranjol, M. Z. I., & Pourgholami, M. H. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.175586 · Cited by 362
Mathematical modeling of tumor-induced angiogenesis
Mantzaris, N. V., Webb, S., & Othmer, H. G. (2004) · Journal of Mathematical Biology · doi:10.1007/s00285-003-0262-2 · Cited by 362
“More comprehensive reviews of the biology can be found in e.g., Paweletz & Knierim (1989); Carmeliet & Jain (2000), and introductory accounts to the entire field can be found in a special issue of Scientific American (275, # 3, Sept (1996)) and (Bicknell et al., 1997).”
BackgroundGOLLOB, J., WILHELM, S., CARTER, C., & KELLEY, S. (2006) · Seminars in Oncology · doi:10.1053/j.seminoncol.2006.04.002 · Cited by 360
Arteriolar and venular patterning in retinas of mice selectively expressing VEGF isoforms
Stalmans, I., Ng, Y.-S., Rohan, R., Fruttiger, M., Bouché, A., Ÿuce, A., Fujisawa, H., Hermans, B., Shani, M., Jansen, S., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214362 · Cited by 358
“Introduction The essential role of VEGF in blood vessel formation in the embryo and in the adult is well established (1, 2).”
BackgroundSelf-citationWachsberger, P. R., Burd, R., & Dicker, A. P. (2003) · PubMed · Cited by 394
Autiero, M., Luttun, A., Tjwa, M., & Carmeliet, P. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00263.x · Cited by 357
Self-citationMacrophages: An Inflammatory Link Between Angiogenesis and Lymphangiogenesis
Corliss, B. A., Azimi, M. S., Munson, J. M., Peirce, S. M., & Murfee, W. L. (2016) · Microcirculation · doi:10.1111/micc.12259 · Cited by 356
“As part of this process, there is aberrant induction of angiogenic and lymphangiogenic processes, which are closely linked to growth and metastasis [36].”
BackgroundContrast‐enhanced MRI for breast cancer screening
Mann, R. M., Kuhl, C. K., & Moy, L. (2019) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.26654 · Cited by 356
“11 This neo-vascularization results in creation of vessels that are leaky.”
Background
Metadata
- Authors
- Carmeliet, P., & Jain, R. K.
- Affiliations
- Vlaams Instituut voor Biotechnologie (BE)
- Harvard University (US)
- ORCID
- Carmeliet, Peter
- Venue
- Nature
- Published
- 2000-09
- Volume
- 407
- Issue
- 6801
- Pages
- 249-257
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1573363574
- Cited by
- 9,070
- References
- 72
- Citations by year
- 2026: 166 · 2025: 208 · 2024: 246 · 2023: 330 · 2022: 335 · 2021: 381 · 2020: 368 · 2019: 349 · 2018: 375 · 2017: 380 · 2016: 378 · 2015: 364 · 2014: 414 · 2013: 412 · 2012: 416
- FWCI
- 19.82
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- pathological angiogenesis, cancer, ischemic diseases, inflammatory diseases, anti-angiogenic therapy, clinical trials
- MeSH terms
- Animals, Disease, Humans, Lymphokines, Neoplasms, Neovascularization, Pathologic, Endothelial Growth Factors, Vascular Endothelial Growth Factors, Vascular Endothelial Growth Factor A
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.